Second Circuit holds that the government will be required to prove more than simple off-label promotion for misbranding prosecutions under the FDCA.
On December 3, the U.S. Court of Appeals for the Second Circuit ruled...more
- FDCA First Amendment Off-Label Promotion Off-Label Use Pharmaceutical
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up to create your digest using LinkedIn*
Back to Top